Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Two-Tier OTC Monograph Approach Could Come With User Fee Revamp

Executive Summary

One tier could provide two-year exclusivity, should FDA request clinical trials for new conditions or ingredients, under a US Senate discussion draft. Essentially stalled monograph process would be replaced by deadlines for FDA action in under two years.

Advertisement

Related Content

Shorter Exclusivity In House OTC Monograph Bill Could Gain Industry Acceptance To Speed Passage
Shorter Exclusivity In House OTC Monograph Bill Could Gain Industry Acceptance To Speed Passage
OTC Monograph Reform Momentum Carries Potential Exclusivity Snag
OTC Monograph Reform Momentum Carries Potential Exclusivity Snag
Pediatric Provision Moves OTC Monograph Reform To Subcommittee Vote
Pediatric Provision Moves OTC Monograph Reform To Subcommittee Vote
Exclusivity Provision Surfaces In OTC Monograph Bill
Exclusivity Provision Surfaces In OTC Monograph Bill
Waiting For Congress: Reforming, Paying For FDA OTC Monograph Program
OTC Monograph User Fees Totaling $22m To $34m Floated In Senate Discussion Draft

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS120699

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel